Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer

被引:1
|
作者
Arora, Ritu [1 ]
Gary, Bernard D. [1 ]
McClellan, Steven [1 ]
Xi, Yaguang [1 ]
Piazza, Gary [1 ]
Reed, Eddie [1 ]
Owen, Laurie [1 ]
Dean-Colomb, Windy [1 ]
机构
[1] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA
关键词
D O I
10.1158/1538-7445.AM2013-5571
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5571
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli
    Yousefi, Hassan
    Van Savage, Isabella
    Okpechi, Samuel C.
    Wright, Maryl K.
    Matossian, Margarite D.
    Collins-Burow, Bridgette M.
    Burow, Matthew E.
    Alahari, Suresh K.
    MOLECULAR CANCER, 2022, 21 (01)
  • [2] Ceritinib is a novel triple negative breast cancer therapeutic agent
    Shengli Dong
    Hassan Yousefi
    Isabella Van Savage
    Samuel C. Okpechi
    Maryl K. Wright
    Margarite D. Matossian
    Bridgette M. Collins-Burow
    Matthew E. Burow
    Suresh K. Alahari
    Molecular Cancer, 21
  • [3] Echinococcus granulosus as a Promising Therapeutic Agent against Triple-negative Breast Cancer
    Sadr, Soheil
    Borji, Hassan
    CURRENT CANCER THERAPY REVIEWS, 2023, 19 (04) : 292 - 297
  • [4] A novel therapeutic approach for triple negative breast cancer
    Boopalan, Thiyagarajan
    Arumugam, Arunkumar
    Suman, Suman
    Das, Trinath P.
    Damodaran, Chendil
    Lakshmanaswamy, Rajkumar
    CANCER RESEARCH, 2012, 72
  • [5] An oncolytic recombinant measles virus is a candidate of a novel therapeutic agent for triple negative breast cancer
    Fujiyuki, T.
    Amagai, Y.
    Shoji, K.
    Sugai, A.
    Awano, M.
    Sato, H.
    Yoneda, M.
    Kai, C.
    HUMAN GENE THERAPY, 2017, 28 (12) : A5 - A5
  • [6] Antitumor activity of the novel mithramycin analog EC8042 in triple negative breast cancer
    Pandiella, A.
    Montero, J. C.
    Cuenca, D.
    Re-Louhau, F.
    Nunez, L. E.
    Moris, F.
    Ocana, A.
    CANCER RESEARCH, 2012, 72
  • [7] Development of a novel therapeutic agent for breast cancer based on a new pathway analysis of triple-negative breast cancer
    Fujimori, Minoru
    Fujita, Tomoyuki
    Mizukami, Tamio
    Okawara, Tadashi
    Inoue, Kengo
    CANCER RESEARCH, 2012, 72
  • [8] Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
    Bowen Gao
    Jiongyu Chen
    Bingchen Han
    Xinfeng Zhang
    Jijun Hao
    Armando E. Giuliano
    Yukun Cui
    Xiaojiang Cui
    Scientific Reports, 11
  • [9] Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
    Gao, Bowen
    Chen, Jiongyu
    Han, Bingchen
    Zhang, Xinfeng
    Hao, Jijun
    Giuliano, Armando E.
    Cui, Yukun
    Cui, Xiaojiang
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer
    Chougule, Mahavir B.
    Patel, Apurva R.
    Jackson, Tanise
    Singh, Mandip
    PLOS ONE, 2011, 6 (03):